Human ABCB1 and ABCG2 confer acquired resistance to Polo-like kinase 1 inhibitors, BI 2536, volasertib and GSK641364

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
JournalCancer Research
Volume74
Issue number19
DOIs
StatePublished - 2014

Cite this